ACMG Assembles New Coalition for Newborn Screening
ACMG, a leading authority in medical genetics and genomics, has taken a significant step to enhance newborn screening systems across the nation. Their Board of Directors is excited to announce the formation of a Newborn Screening Coalition, a commitment that emphasizes the need for evidence-based evaluations of genetic and congenital disorders.
Understanding the Need for a Newborn Screening Coalition
This coalition originates in response to the recent dissolution of the Advisory Committee on Heritable Disorders in Newborns and Children (ACHDNC). Following its cessation, ACMG President Mira B. Irons, MD, FACMG, promptly organized a Taskforce to ensure that newborn screening programs would continue to receive the attention they deserve. By gathering feedback from a wide array of participants in the newborn screening community, this initiative aims to uphold the standards expected by families and healthcare professionals alike.
Role of the Taskforce
The Taskforce, under the leadership of Dr. Irons and chaired by Cynthia Powell, MD, FACMG, held discussions with over 120 stakeholders to gather opinions on how best to maintain oversight and evaluate potential new conditions for inclusion on the Recommended Uniform Screening Panel (RUSP). Their recommendations were well-received and were crucial in moving forward with the establishment of the Coalition.
Goals and Functions of the Coalition
The ACMG Newborn Screening Coalition has clearly defined goals to better serve the public and ensure effective newborn screening processes. By fostering collaboration among various healthcare areas, the Coalition intends to:
- Advise stakeholders and newborn screening programs on conditions that may be included in the RUSP.
- Conduct thorough evidence-based reviews of nominated conditions, allowing public comment prior to making decisions.
- Publish findings and recommendations, detailing the reasoning behind both affirmative and negative votes.
- Promote cooperation across medical fields, laboratories, and public health organizations to guarantee state newborn screening programs are equipped and equitable.
Building A Dedicated Coalition
The Coalition will consist of 15 voting members, bringing together professionals from medical, laboratory, public health, and advocacy sectors. ACMG is reaching out to relevant organizations to nominate representatives, ensuring that a broad spectrum of expertise is included in discussions and decision-making.
Looking Ahead: The Future of Newborn Screening
As the ACMG takes charge of the Coalition, it is committed to ensuring that the procedures for evidence-based reviews remain uninterrupted despite the absence of a federal advisory committee. In collaboration with the ACMG Foundation for Genetic and Genomic Medicine, they are working on a sustainable business plan that aims to officially launch the Coalition in the first quarter of the upcoming year.
Dr. Powell emphasizes the importance of scientific rigor and timely recommendations, stating that families rely on credible information to guide newborn screening programs. The formation of the Coalition guarantees a transparent and collaborative approach to continuing this vital work.
About the American College of Medical Genetics and Genomics
Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) stands as a pivotal player in the realm of medical genetics. As the only medical specialty society in the US that encompasses all facets of medical genetics under one organization, ACMG provides valuable education and resources for over 2,500 professionals dedicated to improving health outcomes through genetics. Their publications include the esteemed journals Genetics in Medicine and Genetics in Medicine Open, which advocate for advancing knowledge in the field.
For additional information about ACMG, please visit acmg.net. The ACMG Foundation for Genetic and Genomic Medicine also plays a crucial role in enhancing educational and public health initiatives through philanthropic support.
Frequently Asked Questions
What is the ACMG Newborn Screening Coalition?
The ACMG Newborn Screening Coalition is a group formed to enhance and oversee newborn screening processes nationally, ensuring rigorous evaluations and recommendations for genetic conditions.
Why was the Newborn Screening Coalition created?
The Coalition was established following the dissolution of the ACHDNC to ensure that newborn screening continues without interruption and to maintain high standards for evidence-based reviews.
How will the Coalition's recommendations be developed?
Recommendations will be based on thorough evidence-based reviews of nominated conditions, allowing for public input before final decisions are made.
Who will be on the Coalition?
The Coalition will include 15 voting members who represent various sectors, including medical, laboratory, public health, and patient advocacy professionals.
When will the Coalition officially launch?
The ACMG Coalition is expected to launch in the first quarter of the upcoming year, with a sustainable business plan currently in development.
